Selection of myocardial infarction (MI) survivors to receive prophylactic implantable cardioverter-defibrillator (ICD) therapy for primary prevention of sudden death requires further elucidation. Although there is a mortality benefit for patients with significantly depressed left ventricular function when ICDs are implanted late after MI, a recent study found no benefit for patients implanted early after MI, despite studies demonstrating a higher risk of sudden death during the early months after MI that decreases with time. The optimal clinical approach to protecting these patients is not known, and data in the present era of primary percutaneous coronary intervention are limited. Our study recruited consecutive patients treated with primary percutaneous coronary intervention for acute ST-elevation MI. Patients with left ventricular ejection fraction Յ40% underwent electrophysiological study followed by ICD implantation in those with inducible ventricular tachycardia Ն200-ms cycle length. The overall mortality of 3% at 1 year was low compared with previous primary prevention studies, and there was no evidence of excess mortality with ICD implantation early after MI. In addition, patients with inducible ventricular tachycardia selected to receive an ICD had a relatively high rate of spontaneous ICD therapy for ventricular arrhythmias of 22%. Although not randomized, this study suggests favorable outcomes with a uniform, systematic primary prevention protocol integrated within an STelevation MI primary percutaneous coronary intervention service. This approach appears to be a rational approach to safely allocate ICD implantation early after ST-elevation MI. See p 194.
Improved Long-Term Survival After Abdominal Aortic Aneurysm Repair
Abdominal aortic aneurysm (AAA) is a common and potentially lethal disease if the AAA ruptures. The disease is preferably treated with prophylactic repair in selected patients. The treatment of AAA has developed substantially over the past 2 decades with the introduction of endovascular aneurysm repair, the timing of intervention established by randomized trials, and improved postoperative care. These developments have made it possible to treat AAA among older patients with more comorbidities while improving short-term outcome. The observed changes in patient demography may, however, affect long-term survival after AAA repair. Longterm survival is fundamental for surgical decision making and has important health economic implications when the cost-effectiveness of a new treatment (eg, endovascular aneurysm repair) or health intervention (eg, screening for AAA) is evaluated. In this populationbased nationwide study, long-term survival after AAA repair in Sweden over an 18-year period was analyzed on the basis of 12 834 primary operations performed from 1987 to 2005. Both short-and long-term outcome after intact AAA repair improved over time. Long-term relative survival among those surviving the operation compared with a general population (adjusted for age, sex, and calendar year) was superior for octogenarians and male patients compared with younger patients and women. Although short-term survival after ruptured AAA repair increased over time, long-term outcome was unaffected. Changes in patient demography and case mix toward older patients, a higher proportion of patients with comorbidities, and the increasing use of endovascular aneurysm repair thus have not had any negative effects on long-term outcome after operation. See p 201.
Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart Study
Cardiovascular disease (CVD) risk factor control is critical to reducing the CVD risk of those with diabetes mellitus. Recent clinical trials have demonstrated that the use of more aggressive targets for blood pressure and cholesterol control among individuals with diabetes mellitus results in a reduced incidence of CVD events. Despite this, data from multiple sources suggest that those with diabetes do not experience optimal risk factor control compared with those without diabetes. Although individuals with diabetes have experienced substantial declines in CVD risk factors, the experience relative to individuals without diabetes has not been well described. The primary goal of this analysis was to characterize the trends in body mass index, blood pressure, cholesterol, and smoking among individuals with and without type 2 diabetes mellitus from 1970 through 2005 in the Framingham Heart Study. Our results showed that compared with those without diabetes mellitus, individuals with diabetes experienced a greater increase in body mass index, a greater decrease in low-density lipoprotein cholesterol, and a similar magnitude of decline in systolic blood pressure. Smoking prevalence has declined among both those with and those without diabetes mellitus. These data showing an independent inverse relationship of dietary glutamic acid (the most common dietary amino acid, especially in vegetable protein) to blood pressure are consistent with previous findings on the inverse relationship of dietary vegetable protein to blood pressure and lend further weight to those results. They generally reinforce current recommendations for a high intake of vegetable products as a part of comprehensive nutritional/lifestyle approaches to preventing and controlling major established cardiovascular risk factors and epidemic cardiovascular disease. See p 221.
Conventional Cardiovascular Risk Factors and Metabolic Syndrome in Predicting Carotid Intima-Media Thickness Progression in Young Adults: The Cardiovascular Risk in Young Finns Study
Accelerated progression in carotid intima-media thickness (IMT) is a marker of atherosclerosis development that is associated with increased risk of cardiovascular events. Exposure to elevated cardio-
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Original Research Put Into Perspective for the Practicing Clinician Volume 120 Ⅲ Number 3 Ⅲ July 21, 2009 vascular risk factor levels and the metabolic syndrome has been shown to predict increased IMT. However, limited longitudinal data are available on the association of risk factors and metabolic syndrome with IMT progression in young adults. On the basis of a large, population-based study of young adults (nϭ1809; aged 24 to 39 years), our results suggest a pathophysiological role of obesity, dyslipidemia, and hyperinsulinemia in predicting atherosclerosis development. In addition, the diagnosis of metabolic syndrome may be helpful in identifying groups of individuals who have accelerated progression of carotid IMT. However, we found no evidence to suggest that metabolic syndrome would predict IMT progression more than would be expected from the sum of its risk components. As shown in our study, adverse developments of lifestyles leading to obesity are translated into accelerated atherosclerosis early in adult life. Therefore, in addition to identification of individuals who are at particularly high risk, a major effort is needed for the reduction of obesity in the entire population of children, adolescents, and young adults to reduce the burden of cardiovascular disease late in their life. See p 229.
Alcohol Consumption and Risk of Cardiovascular Disease and Death in Women: Potential Mediating Mechanisms
Although an association between moderate alcohol consumption and decreased cardiovascular disease (CVD) and death has been reported, limited data are available on potential mediating mechanisms. In a prospective study of 26 399 women, we found a J-shaped association between alcohol consumption and rates of incident CVD, total death, and CVD death in a multivariable model. Compared with abstainers, moderate drinking (5 to 14.9 g/d of alcohol) was associated with 26%, 35%, and 51% lower risk of CVD, total death, and CVD death, respectively, after adjustment for major confounding factors. Under the assumption of a causal relation between moderate drinking and CVD, we estimated the individual and joint contribution of possible mediators of such relation and found that lipids made the largest contribution to the lower risk of CVD (28.7%), followed by hemoglobin A1c/diabetes (25.3%), inflammatory and hemostatic factors (5%), and blood pressure factors (4.6%).
All these mediating factors together explained 86.3%, 18.7%, and 21.8% of the observed lower risk of CVD, total death, and CVD death, respectively, assuming a causal relation between alcohol and outcome. Of note is that the above interpretation is only possible under the causality assumption and does not imply proof of concept from current data. Instead, our data suggest a differential role of a potential mediator of an alcohol and CVD relation. Experimental models are warranted to confirm these hypotheses. In the absence of a definitive answer for humans, the decision on moderate drinking for individual persons should consider the potential risks associated with alcohol intake, along with global CVD risk appraisal. See p 237.
Estrogen Receptor-␤ Activation Results in S-Nitrosylation of Proteins Involved in Cardioprotection
Premenopausal women have reduced cardiovascular disease, and this protection is lost as women enter menopause. A number of studies in animal models have shown that estrogen treatment is cardioprotective. In contrast, the Women's Health Initiative showed no protection with hormone replacement therapy, although some questions have been raised about the age of the women at treatment. This difference emphasizes the need for a better understanding of the mechanism by which estrogen protects in animal studies. This study shows that estrogen acts via the ␤-estrogen receptor in the heart to increase the S-nitrosylation of many proteins that have been shown to be cardioprotective. S-nitrosylation is a common posttranslational protein modification with covalent attachment of a nitric oxide moiety to protein sulfhydryl residues. S-nitrosylation not only leads to changes in the structure and function of target proteins but also prevents the modified cysteine residue(s) from further oxidative modification. These data might prompt future researchers to investigate whether age-related alterations in nitric oxide signaling contribute to the lack of protection by estrogen treatment in older women. It has been suggested that NO signaling might decrease with age because of a decrease in the levels of tetrahydrobiopterin or an increase in arginase activity. Additionally, the finding that a ␤-estrogen-specific agonist is protective provides a potential novel treatment therapy that might promote the beneficial effects of estrogen without specific adverse effects on other tissues such as the uterus. See p 245.
